Cardiovascular magnetic resonance in mild to moderate clozapine-induced myocarditis: Is there a role in the absence of electrocardiographic and echocardiographic abnormalities?

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 6, 2010, Pages 1473-1476

  Ariyarajah, Vignendra ^a   Shaikh, Nasir ^a   Garber, Philip J ^a   Kirkpatrick, Ian ^a   McGregor, Robert ^a   Jassal, Davinder S ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardiovascular magnetic resonance; Clozapine; Late gadolinium enhancement; Myocarditis

Indexed keywords

CLOZAPINE; GADOLINIUM PENTETATE; NEUROLEPTIC AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIARRHEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEVER; HEART MUSCLE BIOPSY; HUMAN; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX PAIN; VOMITING; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; CHEST PAIN; COMPLICATION; PATHOLOGY; PROCEDURES; SCHIZOPHRENIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; CHEST PAIN; CLOZAPINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDITIS; SCHIZOPHRENIA;

EID: 77952868191     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21988     Document Type: Article

References (18)

1. Jann MW. Clozapine. Pharmacotherapy 1991;11:179-195.
2. Novartis Pharmaceuticals Corporation (2003). Clozaril (clozapine). Tablets [product monograph]. Available at: www.Novartis.com Accessed August 26, 2007.
3. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343: 1388-1398.
4. Gagliardi MG, Bevilacqua M, Di Renzi P, Picardo S, Passariello R, Marcelletti C. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 1991;68:1089-1091.
5. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-1258. (Pubitemid 38379570)
6. Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-1822. (Pubitemid 40779862)
7. Belloni E, De Cobelli F, Esposito A, et al. Myocarditis associated with clozapine studied by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2007;9:591-593. (Pubitemid 46399015)
8. Haas SJ, Hill R, Krum H, et al. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Saf 2007;30:47-57.
9. Merrill DB, Dec GW, Goff DC. Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol 2005;25:32-41. (Pubitemid 40129380)
10. Dec GW. Noninvasive imaging techniques for the diagnosis of myocarditis. Heart Fail Clin 2005;1:377-389.
11. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007;26:452-459. (Pubitemid 350194566)
12. Bayés de Luna A, Cino JM, Pujadas S, et al. Concordance of electrocardiographic patterns and healed myocardial infarction location detected by cardiovascular magnetic resonance. Am J Cardiol 2006;97:443-451. (Pubitemid 43190029)
13. Bayés de Luna A, Wagner G, Birnbaum Y, et al. A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circulation 2006;114:1755-1760. (Pubitemid 44608178)
14. Wehmeier PM, Heiser P, Remschmidt H. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. J Clin Pharm Ther 2005;30:91-96. (Pubitemid 41602097)
15. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the periinfarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-39.
16. Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-2743. (Pubitemid 43947991)
17. Maghsoudi A, Ariyarajah V, Al-Mallah M, et al. Abnormal myocardium characterized by late gadolinium enhancement imaging is associated with adverse cardiac prognosis in patients clinically suspected to have non-ischemic or infiltrative cardiomyopathy. J Cardiovasc Magn Reson 2007;2:322. Abstract.
18. Wassmuth R, Lentzsch S, Erdbruegger U, et al. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging - a pilot study. Am Heart J 2001;141:1007-1013. (Pubitemid 32477014)